Recently, Kassem Fawaz’s brother was on a video conference with the microphone muted. Then he noticed that the microphone light was still on—indicating, inexplicably, that his microphone was being accessed….
As an 8-year-old, Noah would pedal around the cul-de-sac in his Madison, Wisconsin, neighborhood, showing off hard-won biking skills his mom had patiently taught him over the course of multiple…
By reprogramming cells from a patient to yield induced pluripotent stem cells, scientists and clinicians can wield a fertile and versatile resource for personalizing patient healthcare via regenerative medicine, cell…
Humans breathe in a mix of air containing roughly 21% oxygen—yet, the oxygen levels in our individual cells vary considerably, depending upon their location and function and our body’s overall…
In the future, with a finger prick and a portable testing device featuring a biosensor, a light source and a camera, you might be able to check your antibody levels…
Walk through any of the buildings on the University of Wisconsin-Madison College of Engineering campus and it won’t take you long to come across a microscope in a research lab….
For Clyde the dog, University of Wisconsin-Madison first-year engineering students have offered one of the greatest gifts of all: renewed freedom to move about on his own. Clyde is a…
It’s hard to say which was the bigger challenge for Gabrielle Ibrahim in 2021: navigating pandemic-enforced travel delays and restrictions to get to her cooperative education experience at Siemens Healthineers…
Immunotherapies, in which care teams harness and augment patients’ immune systems to battle diseases, have emerged as promising treatments for a range of cancers. Yet their effectiveness remains largely blunted…
Melissa Skala, a professor of biomedical engineering at the University of Wisconsin-Madison, has landed a grant from the National Eye Institute to develop a new imaging method for quantifying melanin…
Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment…